Terazosin Hydrochloride
Product Images NDC 67544-562

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Terazosin Hydrochloride (NDC 67544-562). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 2mg (67544 562)

Bottle Label 2mg (67544 562)
Terazosin HCI is a prescription drug that comes in the form of 2mg capsules. It is manufactured by Jubilant Cadista Pharmaceuticals Inc. and is labeled with the National Drug Code (NDC) number 67544-0562-70. The drug should be stored in a cool and dry place between 20-25 degrees Celsius. It is recommended to dispense the medication in a child-resistant container and keep out of the reach of children. The drug is only available with a prescription.*
FDA Label Image

Bottle Label 5mg (67544 563)

Bottle Label 5mg (67544 563)
Terazosin HCI is a medication available in bottles of 60 capsules, each containing 5mg of the active ingredient. The drug should be kept in a controlled room temperature between 20-25 degrees Celsius and out of reach of children. The product is manufactured by Jubilant Cadista Pharmaceuticals Inc in salisbury, MD and repackaged by Aphena Phamia in Cookesville, TN. The NDC number for the product is 67544-0563-53.*
FDA Label Image

Bottle Label 10mg (67544 564)

Bottle Label 10mg (67544 564)
Terazosin HCI 10mg 180 Capsules are a prescription drug item with NDC# 67544-0564-80. They should be stored between 20-25 degrees Celsius (6377 degrees Fahrenheit) and kept in child-resistant containers. This product has been manufactured by Jubilant Cadista Pharmaceuticals Inc in Salisbury, MD, and repackaged by Aghens Pharma in Cookeville, TN. It is important to include this item as RX Only medicine, as prescribed by a doctor.*
FDA Label Image

Bottle Label 1mg (67544 581)

Bottle Label 1mg (67544 581)
This is a description of a prescription drug called Terazosin HCI, which is available in capsule form. The product comes in a bottle with 30 capsules and has a National Drug Code (NDC) number of 67544-0581-30. It should be stored at a temperature range of 20-25 degrees Celsius and kept out of reach of children. The product is manufactured by Jubilant Cadista Pharmaceuticals Inc in Salisbury, MD, and packaged by Athens Pharma in Cookeville, TN. The prescription label indicates that the product is for prescription use only.*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Terazosin Hydrochloride Chemical Structure (Terazosin Hydrochloride Capsules 1)

FDA Label Image

Figure 1 (Terazosin Hydrochloride Capsules 2)

FDA Label Image

Figure 2 (Terazosin Hydrochloride Capsules 3)

Figure 2 (Terazosin Hydrochloride Capsules 3)
This text appears to be a chart or graph with data points representing the mean change from baseline at various time intervals. However, without additional information or context, it is difficult to determine the specific nature or purpose of the chart.*
FDA Label Image

Figure 3 (Terazosin Hydrochloride Capsules 4)

Figure 3 (Terazosin Hydrochloride Capsules 4)
This seems to be a graph showing changes from a baseline measure in some unit (potentially mL/s) over a period of 30 months, with measurements taken at month 0, 1, 2, 3, 6, 12, 15, 18, 21, 24, 27, and 30. No additional information is available in the given text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.